Restless Legs Syndrome and Discontinuation of Bupropion
Stopping bupropion is not established as a trigger for worsening restless legs syndrome (RLS) in the available evidence. citeturn0search0turn0search1turn0search2
Medication-Specific Evidence for Bupropion in RLS
The American Academy of Sleep Medicine (AASM) guideline suggests against using bupropion for the treatment of RLS (conditional recommendation, moderate certainty of evidence). citeturn0search0
A systematic review of antidepressants and RLS reported that bupropion may reduce RLS symptoms at least in the short term. citeturn0search1
A randomized controlled trial in participants with moderate-to-severe RLS found no evidence that bupropion exacerbated RLS symptoms during follow-up, with symptom improvement at 3 weeks in the bupropion group versus placebo. citeturn0search2
Stopping Bupropion: Evidence Gap for Symptom Worsening
Direct evidence addressing whether RLS symptoms worsen after bupropion discontinuation is not provided in the cited guideline, systematic review, or randomized trial. citeturn0search0turn0search1turn0search2
Practical Clinical Management When RLS Symptoms Change
RLS management should include identification and treatment of exacerbating factors, including medication classes and other contributors listed in the AASM guideline. citeturn0search0
When to Reassess RLS Contributors After Medication Changes
If RLS symptoms worsen temporally after stopping bupropion, evaluation should focus on other recognized exacerbating factors rather than assuming a direct discontinuation effect based on current RLS-specific evidence. citeturn0search0
Safety and Monitoring Considerations
RLS symptom monitoring during medication transitions is appropriate because RLS has variable symptom timing and triggers, and RLS-specific discontinuation effects for bupropion are not directly characterized in the cited sources. citeturn0search0turn0search1turn0search2